Damian Green, M.D.With 20 years of experience in stem cell transplantation, oncology and clinical research, Damian Green, M.D., joined Sylvester as chief of the Division of Transplantation and Cellular Therapy and assistant director of translational research in March 2024.
Previously at Fred Hutchinson Cancer Center, Dr. Green's research focuses on blood cancers, particularly multiple myeloma and lymphoma. His work led to the development of innovative immunotherapies targeting CD38, a protein on B cells (white blood cells that produce antibodies to fight infection and disease).
He also pioneered radioimmunotherapy using radiolabeled antibodies and advanced CAR T-cell therapy by enhancing the targeting of B-cell maturation antigen (BCMA) proteins. Although these advancements have improved treatments for blood cancer patients, Dr. Green remains driven to find permanent cures, particularly for multiple myeloma and plans to expand Sylvester’s immunotherapy efforts for blood cancers to offer patients a chance at long-term survival and improved quality of life.
Markus Bredel, M.D.After a rigorous national search, Markus Bredel, M.D., Ph.D., was named chairman of the University of Miami Miller School of Medicine’s Department of Radiation Oncology. Dr. Bredel joined a team dedicated to delivering precision, patientcentered cancer treatment that was the first in South Florida to use HyperArcTM to treat brain tumors and one of the first in the world to offer ViewRay MRIdian® MRIguided radiation therapy. Prior to this, he served as the Sharon A. Spencer Distinguished Endowed Chair in Translational Radiation Oncology at the University of Alabama at Birmingham, where he directed brain tumor research and functional brain radiosurgery.
Dr. Bredel has also held faculty positions at Stanford, Northwestern and the University of Freiburg. He is renowned for his research on gliomas and has published extensively in top medical journals. With expertise in advanced radiosurgery, he contributed to the development of the FDA-approved Varian TrueBeam/Edge platform for essential tremor.